针对整体整合性Helicobacter pylori治疗的有针对性的声动力学治疗平台
Xiaojing Yin1,2, Yongkang Lai1,2,3, Xinyuan Zhang4
1Department of Gastroenterology, Shanghai Institute of Pancreatic Diseases, Changhai Hospital, Shanghai, 200433, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 13, 2024
概括
使用声动疗法的新型纳米平台提供了一种新的方法来根除Helicobacter pylori (H. pylori),甚至是多药耐药菌株,同时保持肠道健康.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 微生物学 微生物学
背景情况:
- 杆菌 (H. pylori) 感染是胃肠道疾病的主要原因,包括胃癌.
- 增加抗生素耐药性和治疗副作用需要使用替代的H. pylori根除策略.
- 目前的疗法在有效性和患者耐受性方面面临挑战.
研究的目的:
- 开发一个有针对性的纳米平台,以有效地根除H. pylori.
- 调查声动力学治疗对H. pylori治疗的潜力.
- 提出一个整合性治疗策略,以保持胃肠道健康.
主要方法:
- 开发一个带有绿色氨酸 (ICG@FCS) 纳米平台的基托结合.
- 使用双重向 (通过福克斯分子,通过超声波物理) 针对H. pylori.
- 采用超声波激活来产生单片氧以产生抗菌作用.
主要成果:
- 该ICG@FCS纳米平台有效地准并透胃粘膜.
- 用ICG@FCS进行声动力疗法证明了对浮游生物,生物膜和细胞内H. pylori的疗效,包括多药耐药菌株.
- 该纳米平台对肠道微生物群的影响最小,并促进胃粘膜修复.
结论:
- ICG@FCS纳米平台代表了H. pylori根除的有希望的替代疗法.
- 这种方法提供了一种整体策略,将病原体清除与胃肠道健康保护相结合.
- 这项研究强调了在打击抗生素耐药性和预防胃癌方面取得的重大进展.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
89
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
89
Peptic Ulcer Disease I: Introduction
139
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
139


